Scleroderma, Diffuse: all 534 studies
Page 5 of 6. Open to participants first (115), then studies with results posted, then the rest; newest registration first within each.
- Scleroderma Treatment With Celution Processed ADRCs RegistryWithdrawnNCT02328625
- Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic SclerosisStatus unknownNCT02302352Phase 3
- Metabolomic Analysis of Systemic SclerosisTerminatedNCT02298777
- Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)WithdrawnNCT02278445Not applicable
- Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)TerminatedNCT02246348Not applicable
- Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by UltrasoundTerminatedNCT02243111Not applicable
- Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT02228850Phase 2
- Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem CellsCompletedNCT02213705Phase 1/2
- Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic SclerosisCompletedNCT02212249Not applicable
- EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSISStatus unknownNCT02206672Not applicable
- Divalproex Sodium in the Treatment of the Cutaneous Manifestations of SclerodermaWithdrawnNCT02166229Phase 1/2
- The Role of Gastroesophageal Reflux in Scleroderma Pulmonary FibrosisStatus unknownNCT02136394
- Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic SclerosisCompletedNCT02105818
- Calcinosis in a Single-Center Scleroderma PopulationCompletedNCT02062125
- Zibotentan Better Renal Scleroderma Outcome StudyCompletedNCT02047708Phase 2
- Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized SclerodermaStatus unknownNCT02002897Not applicable
- Lower Urinary Tract Symptoms in Systemic SclerosisCompletedNCT01971294
- Novel Screening Strategies for Scleroderma PAHCompletedNCT01959815
- Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic SclerosisStatus unknownNCT01943968Not applicable
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Autologous Stem Cell Transplantation for Progressive Systemic SclerosisCompletedNCT01895244Phase 2
- A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With SclerodermaCompletedNCT01881529
- Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
- Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic SclerosisStatus unknownNCT01858259
- Development and Prevention of Pulmonary Hypertension in Systemic SclerosisStatus unknownNCT01840748
- Prevention and Treatment of Digital Ulcers in Systemic SclerosisStatus unknownNCT01836263
- Improvement of Hand Dysfunction by Arthritis in Systemic SclerosisStatus unknownNCT01834157
- Development and Prevention of Severe Heart Disease in Systemic SclerosisStatus unknownNCT01829126
- Oral Health and People With Systemic SclerosisCompletedNCT01817361
- Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot StudyCompletedNCT01813578Not applicable
- Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic SclerosisCompletedNCT01813279Not applicable
- Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal DiseaseStatus unknownNCT01804959Phase 2
- Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for MorpheaCompletedNCT01799174Not applicable
- IVIG Treatment in Systemic SclerosisStatus unknownNCT01785056Not applicable
- Morbidity and Mortality Follow Up for the Scleroderma Lung StudyCompletedNCT01762449
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.CompletedNCT01743612Not applicable
- Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary HypertensionCompletedNCT01729611
- Sacroiliitis in Systemic SclerosisCompletedNCT01673633
- Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and CoughCompletedNCT01667042
- Proof of Biological Activity of SAR100842 in Systemic SclerosisCompletedNCT01651143Phase 2
- Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic SclerosisWithdrawnNCT01639573
- Serial Night Time Position Splint on Systemic SclerosisStatus unknownNCT01586663Phase 3
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic StudyStatus unknownNCT01554540Phase 1/2
- A Trial of Tadalafil in Interstitial Lung Disease of SclerodermaCompletedNCT01553981Phase 3
- Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy PeoplesStatus unknownNCT01553890Not applicable
- Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse SclerodermaTerminatedNCT01545427Phase 2
- Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic SclerosisWithdrawnNCT01497743Phase 4
- Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic SclerosisCompletedNCT01488214Not applicable
- Hemodynamic Changes in Connective Tissue DiseaseCompletedNCT01468792
- Immunoadsorption in Patients With Severe Systemic SclerosisTerminatedNCT01410903Not applicable
- Digital UlcerationCompletedNCT01377090
- Post Marketing Surveillance Study of CuprimineNo longer availableNCT01374282
- Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDYCompletedNCT01295736Phase 3
- Fresolimumab In Systemic SclerosisCompletedNCT01284322Phase 1
- Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic SclerosisCompletedNCT01270425
- Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis PatientsWithdrawnNCT01202045
- A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaCompletedNCT01117298Phase 3
- Finger Hardness Measure in SclerodermaCompletedNCT01111786
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic SclerosisWithdrawnNCT01047072Phase 2
- Influenza Vaccination in Patients With SclerodermaStatus unknownNCT01002508Phase 4
- Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary HypertensionCompletedNCT00984932Phase 3
- Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)Status unknownNCT00962923Phase 1/2
- Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule EndoscopyCompletedNCT00958672
- The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00946738Not applicable
- A Study of the Safety and Tolerability of MEDI-551 in SclerodermaCompletedNCT00946699Phase 1
- A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With SclerodermaCompletedNCT00930683Phase 1
- Early Therapy of Pulmonary Arterial HypertensionCompletedNCT00909337Not applicable
- SCOT Scleroderma Treatment Alternative Registry (STAR Registry)CompletedNCT00860548
- Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate MofetilCompletedNCT00853788
- Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesTerminatedNCT00849745Phase 1
- Pharmacokinetics of Oral Treprostinil in Patients With Systemic SclerosisCompletedNCT00848939Phase 1
- Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic SclerosisCompletedNCT00843102
- AIMSPRO in Established Diffuse Cutaneous Systemic SclerosisStatus unknownNCT00769028Phase 2
- Effectiveness and Safety of Lidocaine for SclerodermaCompletedNCT00740285Phase 2/3
- Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual DysfunctionCompletedNCT00707187Phase 2
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)TerminatedNCT00706082
- Recombinant Human Relaxin in the Treatment of Diffuse SclerodermaCompletedNCT00704665Phase 3
- Cardiac Repercussion of Systemic SclerodermiasCompletedNCT00697736Not applicable
- Angiogenic/Angiostatic Mediators in Patients With Systemic SclerosisCompletedNCT00668473
- Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic SclerosisCompletedNCT00667134
- Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic SclerosisTerminatedNCT00628797Phase 1/2
- Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaCompletedNCT00626665Phase 3
- Sildenafil for Treatment of Digital Ulcers in Patients With Systemic SclerosisCompletedNCT00624273Phase 2
- Effect of Different Iloprost Doses on Symptoms in Systemic SclerosisTerminatedNCT00622687Phase 2
- Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT00617487
- Pulmonary Artery Remodelling With BosentanCompletedNCT00595049Phase 4
- QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic SclerosisTerminatedNCT00581997Phase 2
- A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's PhenomenonStatus unknownNCT00577304Phase 3
- Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic SclerosisCompletedNCT00574613Phase 2
- Low-Dose Oral Imatinib for Scleroderma Pulmonary InvolvementStatus unknownNCT00573326Phase 2
- Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma PatientCompletedNCT00566137
- CLUE Study: Connective Tissue Disease Leg Ulcer Etiology StudyCompletedNCT00522002
- Duke Autoimmunity in Pregnancy RegistryCompletedNCT00513591
- Efficacy and Safety of Imatinib in SclerodermaCompletedNCT00479934Phase 2
- UVA1 Light for Treatment of Scleroderma and Similar ConditionsCompletedNCT00476801Not applicable
- UVA1 Light for Scleroderma and Similar ConditionsTerminatedNCT00476697Not applicable
- Platelet Gel in Systemic SclerosisStatus unknownNCT00463125Phase 2/3
- Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic SclerosisStatus unknownNCT00453752